RHT — Resonance Health Income Statement
0.000.00%
Last trade - 00:00
- AU$32.68m
- AU$27.11m
- AU$4.51m
- 70
- 39
- 73
- 64
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.66 | 3.71 | 3.82 | 3.83 | 4.51 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.76 | 4.66 | 3.38 | 5.58 | 6.06 |
Operating Profit | 0.904 | -0.949 | 0.432 | -1.74 | -1.55 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.942 | -0.953 | 0.344 | -1.55 | -1.26 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.27 | -0.715 | 0.586 | -1.14 | -0.78 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.27 | -0.715 | 0.586 | -1.14 | -0.78 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.27 | -0.715 | 0.586 | -1.14 | -0.78 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.002 | 0.001 | -0.003 | -0.002 |